Fusion event
HBV-HSFY1 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGC| |ACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGG
End
20717023/18555137 (Hg38)
Nearest miRNA
hsa-mir-12120/Upstream/5075871;
Upstream sequence
cataggtatgtcagatatccccagtagcctgaacctagacaagggttacatcacttaggtgatcagcatagagatatgtgaaaattcccgtctagacaca
Downstream sequence
aaagaaactccatctcaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaCACAACAACAAAAAAAGAACGAAAAGAAAAAAAAAAGTTGCTGACTAGT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.